Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Muscle Nerve. 2018 Nov 26;59(2):201–207. doi: 10.1002/mus.26335

Table 2.

Outcome Measures: rasagiline n=60, placebo n=20

Average Slope per Month (SD / 95% CI)
Outcome Placebo Rasagiline Difference Ras - Plac % Difference p-Value
ALSFRS-R −1.25 (0.22 / −1.70,−0.81) −1.01 (0.13 / −1.27,−0.75) 0.24 (0.26 / −0.27,0.76) 20 0.35
FVC % −2.48 (0.54 / −3.54,−1.43) −2.24 (0.31 / −2.86,−1.64) 0.24 (0.62 / −0.98,1.45) 11 0.65
ALSQoL 0.12 (0.03 / −0.18,−0.05) 0.09 (0.02 / −0.13,−0.06) 0.03 (0.04 / −0.05,0.09) 21 0.47

SD = standard deviation; CI = confidence interval; Ras = rasagiline; Plac = placebo;